Availability and variability in guidelines on diabetic retinopathy screening in Asian countries
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Diabetic retinopathy (DR) is a blinding yet treatable complication of diabetes. DR screening is highly cost-effective at reducing blindness. Amidst the rapidly growing diabetic population in Asia, the prevalence of DR in the region is relatively less well known. AIMS: To review existing national DR screening guidelines of 50 countries in Asia, compare them against the International Council of Ophthalmology (ICO) guideline, and summarise the prevalence rates of DR and sight-threatening DR (STDR) in these countries. METHODS: We systematically searched for published guidelines from the National Guideline Clearinghouse and other databases, and contacted local diabetic and ophthalmological associations of all 50 Asian countries. RESULTS: Eleven Asian countries have published relevant guidelines, nine of which pertain to general diabetes care and two are DR-specific, covering less than half of Asia's population. The median DR prevalence among patients with diabetes is 30.5% (IQR: 23.2%-36.8%), similar to the USA and the UK. However, rates of STDR are consistently higher. All guidelines from the 11 Asian countries fulfil the ICO standard on when to start and repeat screening, except for screening interval for pregnant patients. However, only 2 of the 11 guidelines fulfil the ICO referral criteria and 6 partially fulfil. A third of the recommendations on screening process, equipment and personnel is either unavailable or incomplete. CONCLUSIONS: Countries in Asia need to establish more comprehensive and evidence-based DR screening guidelines to facilitate the execution of robust screening programmes that could help reduce DR-related blindness, improve patient outcomes and reduce healthcare costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Self-citationCheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Self-citationDiabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997
Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial
(1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.7.874 · Cited by 509
Metabolic Control and Progression of Retinopathy: The Diabetes in Early Pregnancy Study
Chew, E. Y., Mills, J. L., Metzger, B. E., Remaley, N. A., Jovanovic-Peterson, L., Knopp, R. H., Conley, M., Rand, L., Simpson, J. L., Holmes, L. B., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.631 · Cited by 402
Gupta, J. K., Daniels, J. P., Middleton, L. J., Pattison, H. M., Prileszky, G., Roberts, T. E., Sanghera, S., Barton, P., Gray, R., Kai, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19880 · Cited by 399
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Epidemiology of proliferative diabetic retinopathy
Klein, R., Klein, B. E. K., & Moss, S. E. (1992) · Diabetes Care · doi:10.2337/diacare.15.12.1875 · Cited by 344
Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries
Ruta, L. M., Magliano, D. J., LeMesurier, R., Taylor, H. R., Zimmet, P. Z., & Shaw, J. E. (2013) · Diabetic Medicine · doi:10.1111/dme.12119 · Cited by 311
Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy
Rosenn, B., Miodovnik, M., Kranias, G., Khoury, J., Combs, C. A., Mimouni, F., Siddiqi, T. A., & Lipman, M. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90608-5 · Cited by 169
Cited by
Ting, D. S. W., Cheung, C. Y.-L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., Hamzah, H., Garcia-Franco, R., San Yeo, I. Y., Lee, S. Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.18152 · Cited by 2,402
Self-citationGuidelines on Diabetic Eye Care
Wong, T. Y., Sun, J., Kawasaki, R., Ruamviboonsuk, P., Gupta, N., Lansingh, V. C., Maia, M., Mathenge, W., Moreker, S., Muqit, M. M. K., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.007 · Cited by 839
Self-citationA deep learning system for detecting diabetic retinopathy across the disease spectrum
Dai, L., Wu, L., Li, H., Cai, C., Wu, Q., Kong, H., Liu, R., Wang, X., Hou, X., Liu, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23458-5 · Cited by 620
“Although routine DR screening is recommended by all professional societies, comprehensive DR screening is not widely performed 6 – 10 , facing the challenges related to the availability of human assessors 3,11 .”
BackgroundKropp, M., Golubnitschaja, O., Mazurakova, A., Koklesova, L., Sargheini, N., Vo, T.-T. K. S., de Clerck, E., Polivka, J., Potuznik, P., Polivka, J., et al. (2023) · EPMA Journal · doi:10.1007/s13167-023-00314-8 · Cited by 468
Cen, L.-P., Ji, J., Lin, J.-W., Ju, S.-T., Lin, H.-J., Li, T.-P., Wang, Y., Yang, J.-F., Liu, Y.-F., Tan, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25138-w · Cited by 346
Metadata
- Authors
- Wang, L. Z., Cheung, C. Y., Tapp, R. J., Hamzah, H., Tan, G., Ting, D., Lamoureux, E., & Wong, T. Y.
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2017-03-14
- Volume
- 101
- Issue
- 10
- Pages
- 1352-1360
- ISSN
- 0007-1161 (ISSN-L)
- 1468-2079
- OpenAlex
- W2597318018
- Cited by
- 91
- References
- 10
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. https://app.cochat.ai/papers/10.1136/bjophthalmol-2016-310002
- The paper
- Wang, L. Z., Cheung, C. Y., Tapp, R. J., Hamzah, H., Tan, G., Ting, D., Lamoureux, E., & Wong, T. Y. (2017). Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2016-310002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.